African HIV Treatment Advocate Forum
The African Eye Trust has organised two training sessions in London targeting people of African origin living with or affected by HIV. The course aims at training members of staff and volunteers to become HIV Treatment Advocates. With appropriate training, the HIV treatment advocate will offer individualised patient support, governed by harm reduction principles that can increase medication adherence, reduce hospitalisations, and improve the quality of life for those with HIV.
Today, more than 40 million people are living with HIV/AIDS and many more are affected indirectly through family members becoming ill or dying from the disease. However, the real story of HIV/AIDS is not happening at the global level but in the streets, settlements, families and communities that make up the cities, nations and the world as a whole. It is at the community level where action is needed and counts most. According to HPA report 2006, HIV and AIDS continues to disproportionately affect African communities living in the UK over other communities.
The complexity of HIV disease management calls for innovative holistic measures to ensure the greatest quality of life for those who are affected. The treatment advocate project is a low threshold and low-cost means of improving HIV patient care. Working within a multi-disciplinary team structure, treatment advocates are able to provide intensive patient support, particularly around adherence, that can both enhance treatment outcomes and improve the quality of life for people with HIV.
The African Eye Trust provides various community activities based on a holistic health promotion approach seeking to empower the African communities living in the UK with necessary skills, knowledge, attitudes, behaviours, and capability to address HIV/AIDS effectively.
For more information please email our Lead Trainer Mike Hizza
Please click here to download the application form below.
For Directions to training Sites please click on the links below:
- The African Eye Trust Training Site Venue and Map
- MRC training Site Venue address and Map
Clinical trials
MRC: about clinical trials
MRC main page
Information on the PIVOT trial:
PIVOT leaflet: click here
Trial information: click here
HCQ01 Trial information:
HCQ01 Trial leaflet: click here
Training plans: 2010
HIV Treatment Advocates Training Schedule
Day One: 20th January 2010
Location: The African Eye Trust, 65 Kings Cross Road, London WC1X 9LW
|
TIME |
TOPIC |
FACILITATOR |
|
10:00-10:10 |
Registration/ground rules |
TAET Team |
|
10:10-10.30 |
Evaluation 2008- London training |
TAET Team |
|
10:30-11:30 |
The Human Anatomy |
TAET Team |
|
11:50-13:00 |
What are clinical trials/PIVOT |
TAET Team |
|
14:00-15:00 |
The role of social workers in HIV care |
TAET Team |
|
15:00-15:30 |
The doctor-patient relationship |
TAET Team |
|
15:30-16:00 |
BHIVA conference feedback |
TAET Team |
|
16:00 |
End |
|
Day Two: 2nd February 2010
Location: MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA
|
TIME |
TOPIC |
FACILITATOR |
|
10:00-11:30 |
The qualities of an advocacy (treatment) |
TAET Team |
|
11:50-13:00 |
HIV treatment and managing side effects |
TAET Team |
|
14:00-15:00 |
Group work and feedback |
All participants |
|
15:00-15:30 |
Action plan |
All participants |
|
16:00 |
End |
|
Latest news from aidsmap.com
- Cotrimoxazole cuts mortality for symptomatic patients with HIV in areas with low malaria prevalence
- Good early increases in CD4 count reduce mortality risk for malnourished HIV patients
- `No sex` months proposed as fire-break for HIV in worst-affected countries
- Malaria symptoms should raise suspicion of HIV in sub-Saharan Africa
- UK restrictions on access to healthcare result in migrants delaying HIV tests and treatment
- South Africa: HIV infection rate slowing, study reports
- South African doctors report successful kidney transplants between people with HIV
- Timing of ART initiation during TB treatment may not have significant impact on risk of death
- HIV counselling increases condom use in TB patients
- Increasing testing for HIV in TB patients feasible without additional resources


